Easton Pharmaceuticals, Inc. (EAPH)

[Cuse3]

Potential is here but it's going to take awhile.

1) Lawsuit cleared up - Could be a long while before any of this is taken care of. The legal system isn't exactly a quick process

2) Def not unlimited potential in the Canadian mmj area. Health Canada projects 58,000 patients by the end of 2014. That's it, 58k. spread amongst only 15-20 licensed growers. Assuming EAPH makes that list, and gets a complete equal share of all the customers. That's only 3,866 patients per grow op. And to be fair EAPH doesn't own 100% of the op just the right to purchase up to 50%, so again assuming they purchase 50% that's only 2k patients. Now by 2024 the projected number of patients is 1% of the pop @ 450k, and by then I agree the money will be there, granted the amount of growers doesn't grow 10 fold.

Where in the heck do you see .18 cents a share. They made it to .08 in March, but wow, that's not even close to right. Of course they have other possible revenue streams, but those are still iffy at best. Viorra has been touted for a few years now to no avail, and AMFIL is just a % again. Do we have any idea what % they currently own in AMFIL or the grow op?